| Financial Year |
March 31 2023 |
| Monetary Funds |
50,794,037.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
500,000.00 |
| Accounts Receivable |
27,758,564.78 |
| Advances to Suppliers |
2,752,011.16 |
| Other Receivables |
3,549,827.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
60,430,251.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,254,158.67 |
| Total Current Assets |
147,038,851.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
11,589,996.61 |
| Fixed Assetes |
1,368,168.41 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
925,887.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
451,858.59 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
20,783,274.32 |
| Total Assets |
167,822,125.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
38,823,285.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,545,658.69 |
| Taxes Payable |
2,222,898.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,986,095.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,092,817.58 |
| Other Current Liabilities |
473,672.21 |
| Sub-Total of Current Liabilities |
77,030,726.23 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
547,908.86 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,164,104.92 |
| Total Liabilities |
81,194,831.15 |
| Paid-In Capital(Or Share Stock) |
270,272,800.00 |
| Capital Surplus |
337,642,176.17 |
| Surplus Reserve |
27,388,843.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-562,655,167.21 |
| Minority Stockholder's Interest |
13,978,642.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
72,648,652.12 |
| Owner's Equity（Stockholder's Equity） |
86,627,294.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
167,822,125.60 |
